V015-2690 Screening compound: N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)adamantane-1-carboxamide

V015-2690 Screening compound: N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)adamantane-1-carboxamide
V015-2690 Screening compound: N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)adamantane-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-2690
N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)adamantane-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-2690

Molecular Formula

C27H27F3N2O2S (C27 H27 F3 N2 O2 S)

Compound Name

N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-1,3-thiazolidin-2-yl}phenyl)adamantane-1-carboxamide

IUPAC name

N-(3-{4-oxo-3-[4-(trifluoromethyl)phenyl]-13-thiazolidin-2-yl}phenyl)adamantane-1-carboxamide

SMILES

O=C(C1(CC(C2)C3)CC3CC2C1)Nc1cccc(C(N2c3ccc(C(F)(F)F)cc3)SCC2=O)c1

InChI

InChI=1S/C27H27F3N2O2S/c28-27(29,30)20-4-6-22(7-5-20)32-23(33)15-35-24(32)19-2-1-3-21(11-19)31-25(34)26-12-16-8-17(13-26)10-18(9-16)14-26/h1-7,11,16-18,24H,8-10,12-15H2,(H,31,34)/t16?,17?,18?,24-,26?/m0/s1

InChI Key

BFYVDYQHXWDWAY-TWSMWQQMSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

500.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.739

Distribution Coefficient, logD

6.738

Water Solubility, LogSw

-6.25

Polar Surface Area

39.257

Acid Dissociation Constant (pKa)

11.28

Base Dissociation Constant (pKb)

1.87

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

48.10

V015-2690 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

GABA Library (7115 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Eye
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V015-2690 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-2690?
Check Price and Availability of V015-2690, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-2690 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-2690
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-2690
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-2690 available by request